Brenda L Gallie Selected Research

Kinesins

1/2014	Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
4/2012	Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
6/2007	KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer.
2/2007	Profiling genomic copy number changes in retinoblastoma beyond loss of RB1.
9/2006	KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.
2/2002	Genomic amplification in retinoblastoma narrowed to 0.6 megabase on chromosome 6p containing a kinesin-like gene, RBKIN.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brenda L Gallie Research Topics

Disease

51	Retinoblastoma (Glioblastoma, Retinal) 04/2022 - 02/2002
34	Neoplasms (Cancer) 11/2021 - 08/2003
8	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2004
2	Cicatrix (Scar) 01/2020 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 12/2014 - 04/2012
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2014 - 01/2004
2	Lung Neoplasms (Lung Cancer) 04/2012 - 06/2007
2	Carcinogenesis 02/2012 - 07/2005
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2012 - 12/2007
2	Breast Neoplasms (Breast Cancer) 09/2006 - 07/2005
1	Retinal Detachment (Retinal Detachments) 01/2022
1	Capsule Opacification 01/2022
1	Cataract (Cataracts) 01/2022
1	Burns 01/2020
1	Gliosis 01/2020
1	Diabetes Mellitus 01/2019
1	Iron Overload 01/2019
1	Amblyopia (Lazy Eye) 01/2019
1	Anemia 01/2019
1	Ototoxicity 01/2018
1	Neuroblastoma 01/2018
1	Strabismus (Squint) 01/2018
1	Hearing Loss (Hearing Impairment) 01/2018
1	Second Primary Neoplasms (Neoplasms, Second) 03/2017
1	Hypersensitivity (Allergy) 02/2015
1	Thrombosis (Thrombus) 02/2015
1	Kidney Neoplasms (Kidney Cancer) 01/2012
1	Hypoxia (Hypoxemia) 08/2009
1	Toxocariasis 03/2009
1	Eosinophilia 03/2009
1	Blindness (Hysterical Blindness) 09/2008
1	Aneuploidy (Aneuploid) 05/2008
1	Genomic Instability 05/2008

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 12/2014 - 10/2002
10	Messenger RNA (mRNA)IBA 12/2014 - 09/2004
9	Retinaldehyde (Retinal)IBA 01/2020 - 09/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2002
6	KinesinsIBA 01/2014 - 02/2002
4	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 08/2003
4	Topotecan (Hycamtin)FDA LinkGeneric 02/2015 - 09/2009
4	RNA (Ribonucleic Acid)IBA 01/2012 - 10/2002
3	Nonsense Codon (Nonsense Mutation)IBA 10/2021 - 05/2009
3	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 02/2015 - 06/2011
3	MicroRNAs (MicroRNA)IBA 01/2014 - 07/2007
3	Tumor Viral Antigens (Large T Antigen)IBA 09/2011 - 09/2004
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2009 - 03/2005
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 02/2012 - 10/2008
2	osteoblast cadherinIBA 09/2011 - 09/2004
2	Etoposide (VP 16)FDA LinkGeneric 09/2009 - 03/2005
2	Vincristine (Oncovin)FDA LinkGeneric 09/2009 - 03/2005
2	Retinoblastoma ProteinIBA 04/2007 - 09/2004
1	ElementsIBA 04/2022
1	Iodine-125IBA 10/2021
1	IronIBA 01/2019
1	DeferiproneIBA 01/2019
1	Deferasirox FDA Link 01/2019
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2019
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018
1	antiarrhythmic peptide (AAP)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Anesthetics (Anesthetic Agents)IBA 12/2016
1	Aprotinin (Trasylol)FDA Link 02/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2014
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 08/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	IntegrinsIBA 12/2012
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 02/2012
1	Proteasome InhibitorsIBA 02/2012
1	Small Interfering RNA (siRNA)IBA 02/2012
1	Carbonic Anhydrase IIIBA 09/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2009
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2009
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2009
1	Immunoglobulin E (IgE)IBA 03/2009
1	Proto-Oncogene Proteins c-mdm2IBA 10/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2008

Therapy/Procedure

24	Drug Therapy (Chemotherapy) 01/2022 - 08/2003
14	Therapeutics 01/2022 - 08/2003
7	Lasers (Laser) 01/2022 - 06/2011
3	Radiotherapy 01/2022 - 10/2021
3	Injections 02/2015 - 08/2003
2	Light Coagulation 01/2020 - 01/2019
2	Laser Therapy (Surgery, Laser) 01/2019 - 02/2015
2	Eye Enucleation (Enucleation, Eye) 01/2015 - 09/2009
2	Cryotherapy (Therapy, Cold) 10/2014 - 06/2011
1	Vitrectomy 01/2022
1	Combined Modality Therapy 11/2021
1	Traction 01/2020
1	Secondary Prevention 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Anesthesia 01/2018
1	Salvage Therapy 12/2016
1	Aftercare (After-Treatment) 12/2013
1	Long-Term Care 04/2013
1	Consolidation Chemotherapy 08/2010
1	Catheters 09/2008